The dimerization of MLL N-terminal exons resulting from in-frame partial tandem duplications of 5′ MLL regions (MLL-PTDs) has also been identified in AML patients comprising 4% of the MLL-r leukemia [41,42]. Here, KMT2A is linked to leukemia.